我要投票 千金药业在女性洗液行业中的票数:157
· 外 推 电 报 ·
2025-02-23 12:56:41 星期日

【千金药业是哪个国家的品牌?】

千金药业是什么牌子?「千金药业」是 株洲千金药业股份有限公司 旗下著名品牌。该品牌发源于湖南省株洲市,由创始人江端预在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力千金药业品牌出海!通过在本页面挂载千金药业品牌的产品链接和联系邮箱,可以提高千金药业产品曝光!跨境电商爆单神器,目前只要100元/年哦~

株洲千金药业股份有限公司,前身为株洲市中药厂,1993年进行股份制改造,2004年上市(股票代码:600479),千金药业系国家大中型中药制药企业。旗下拥有十三家控股子公司。

千金药业注册资本3.05亿元,2013年底,总资产达到18.88亿元。经济效益综合指标在湖南省医药行业同行中排名第一,位居国内中药行业前列。

公司拥有国内最大、工艺最成熟的中药片剂生产线,日产量为1200万片,年产量可达35亿片。硬件装备先进,达到国内领先水平。2009年12月,位于河西天元区栗雨工业园的千金女性健康产业基地正式投产,该基地建设属国家高新技术产业项目,占地200亩达产规模30亿元。

公司专注于女性健康产业,已形成女性健康系列产品。公司现有片剂、颗粒剂、硬胶囊剂等八个剂型,十三条生产线,全部通过GMP认证。主要产品有:妇科千金片(胶囊)、补血益母颗粒、养阴清肺糖浆、千金椿乳凝胶、痛经宁糖浆(胶囊)、乳癖康胶囊妇科调经片、千金宁洗液、千金止带丸、八珍益母片、加味逍遥丸、乳泉颗粒等。

公司现有14个独家产品,近50个生产批文,拥有各项专利206件。其中主导产品妇科千金片(胶囊)是国家中药保护品种、国家基本药物,国家医保目录甲类品种,《中国药典》收载品种,国家秘密技术项目,是唯一列入国家秘密技术的妇科中成药品种。

千金药业及下属子公司现有员工4000余人,其中总部员工1800余人,大专以上学历人员超过52%,平均年龄为29岁,在职职业药师40余名。公司建立了近千人的专业化特质营销队伍,在全国除西藏、台湾、香港、澳门外的30多个省市设有联络处。

公司“十二五”战略目标是:成为女性健康领域标杆企业,成为中药衍生领域品牌产品;实现集团公司年销售收入达40亿元;实现员工收入增长翻番;使千金药业成为“快乐千金”、“和谐千金”、“富裕千金”和“品牌千金”。

发展历程

▲1966年:在株洲市徐家桥永安仁药店后,株洲千金药业股份有限公司的前身——株洲市中药加工厂(即株洲市医药公司星火中成药加工厂)成立。生产参苏丸、五积散等产品;注册商标为“火炬”。

▲1968年:更名为株洲市六二六制药厂,开始生产町水糖浆剂、丸剂和片剂。

▲1973年:六二六制药厂搬迁到金钩山路的原市委党校校址。

▲1975年:更名为株洲市中药制药厂。

▲1976年:启动“妇科千金片”研制。

▲1979年:注册使用“牡丹”商标;同年,妇科千金片获得生产批文并开始试生产。

▲1981年:被株洲市政府列为关、停、并、转的对象;同年,妇科千金片消毒灭菌技术攻关获得成功。

▲1983年:“妇科千金片”被评为湖南省优质产品。

▲1984年:牡丹牌“脑乐静”被评为湖南省优质产品。

▲1985年:“妇科千金片”被国家医药管理局评为优质产品。

▲1987年:更名为株洲市中药厂。

▲1991年:妇科千金片荣获国优银质奖。

▲1993年:改组为株洲千金药业股份有限公司;同年,妇科千金片销往新加坡。

▲1994年:妇科千金片入选国家基本药物。

▲1995年:“千金”牌商标获国家工商局注册商标证书。

▲1996年:“妇科千金片”被认定为1995年度湖南名牌产品。

▲1998年:成立陇西药材分公司。同年,湘江药业股份有限公司成立,千金药业投资816万元,占总股本的51%。同年,株洲千金医药贸易有限公司成立,注册资本500万元,千金药业和湘江药业分别投资480万元和20万元。

英文翻译:Zhuzhou Qianjin Pharmaceutical Co., Ltd., formerly Zhuzhou traditional Chinese medicine factory, was transformed into a joint-stock company in 1993 and listed in 2004 (Stock Code: 600479). Qianjin pharmaceutical is a large and medium-sized national traditional Chinese medicine pharmaceutical enterprise. It has 13 holding subsidiaries. Qianjin pharmaceutical has a registered capital of 305 million yuan, and by the end of 2013, its total assets reached 1888 million yuan. The comprehensive index of economic benefit ranks the first among the medical industry peers in Hunan Province, and ranks in the forefront of the domestic traditional Chinese medicine industry. The company has the largest and most mature production line of traditional Chinese medicine tablets in China, with a daily output of 12 million tablets and an annual output of 3.5 billion tablets. The hardware equipment is advanced, reaching the leading level in China. In December 2009, the Qianjin women's health industrial base, located in Liyu Industrial Park, Tianyuan District, Hexi, was officially put into operation. The construction of the base is a national high-tech industrial project, covering an area of 200 mu and reaching a production scale of 3 billion yuan. The company focuses on women's health industry and has formed a series of women's health products. The company has eight dosage forms such as tablet, granule, hard capsule and thirteen production lines, all of which have passed GMP certification. The main products are: gynecological Qianjin tablets (capsules), blood enriching mother granule, Yangyin Qingfei syrup, Qianjin Chun milk gel, dysmenorrhea syrup (capsule), Rupikang capsule, gynecological regulating menstruation tablets, Qianjin Ning lotion, Qianjin Zhibao pills, eight Zhen Yi Mu tablets, Jiawei Xiaoyao pills, and Ruquan granules. The company has 14 exclusive products, nearly 50 production approvals and 206 patents. Among them, the leading product Fukeqianjin tablet (capsule) is the national traditional Chinese medicine protection variety, the national basic drug, the category a variety in the national medical insurance catalog, the variety included in the Chinese Pharmacopoeia, and the national secret technology project. It is the only variety of Chinese traditional medicine for gynecology listed in the national secret technology. Qianjin Pharmaceutical Co., Ltd. and its subsidiaries have more than 4000 employees, including more than 1800 employees in the headquarters, more than 52% of them with college degree or above, with an average age of 29 and more than 40 on-the-job professional pharmacists. The company has established a professional marketing team of nearly one thousand people, with liaison offices in more than 30 provinces and cities except Tibet, Taiwan, Hong Kong and Macao. The company's "12th Five Year Plan" strategic goal is: to become a benchmark enterprise in the field of women's health and a brand product in the field of traditional Chinese medicine derivatives; to realize the annual sales revenue of the group company reaching 4 billion yuan; to realize the doubling of the income growth of employees; to make Qianjin pharmaceutical industry become "happy Qianjin", "harmonious Qianjin", "rich Qianjin" and "brand Qianjin". Development history ▲ 1966: after xujiaqiao yong'anren drugstore in Zhuzhou City, Zhuzhou Qianjin Pharmaceutical Co., Ltd., the predecessor of Zhuzhou traditional Chinese medicine processing factory (i.e. Xinghuo traditional Chinese medicine processing factory of Zhuzhou pharmaceutical company), was established. Production of Shensu pill, Wuji powder and other products; the registered trademark is "Torch". In 1968, it was renamed Zhuzhou 626 pharmaceutical factory and began to produce machishui syrup, pills and tablets. ▲ 1973: the 626 pharmaceutical factory was moved to the original site of the Party School of the municipal Party committee of jinyushan road. ▲ 1975: renamed Zhuzhou traditional Chinese medicine pharmaceutical factory. ▲ 1976: launch the development of "gynecology Qianjin tablet". In 1979, "Peony" trademark was registered and used; in the same year, gynecology Qianjin tablet obtained production approval and began trial production. In 1981, it was listed by Zhuzhou municipal government as the target of "close, stop, merge and transfer"; in the same year, the disinfection and sterilization technology of gynecology Qianjin tablet was successfully tackled. ▲ in 1983, "gynecology Qianjin tablet" was rated as high quality product of Hunan Province. ▲ 1984: Peony brand "Naolejing" was rated as high quality product of Hunan Province. In 1985, "gynecology Qianjin tablet" was rated as a high-quality product by the State Administration of medicine. ▲ 1987: renamed Zhuzhou traditional Chinese medicine factory. ▲ 1991: Gynecology Qianjin tablet won the national excellent silver medal. In 1993, it was reorganized into Zhuzhou Qianjin Pharmaceutical Co., Ltd. in the same year, Qianjin tablets for gynecology were sold to Singapore. ▲ 1994: Gynecology Qianjin tablet was selected as the national basic drug. ▲ in 1995, "Qianjin" brand trademark obtained the registered trademark certificate of the State Administration for Industry and commerce. In 1996, "gynecology Qianjin tablet" was recognized as the famous brand product of Hunan in 1995. ▲ 1998: Longxi herbal medicine branch was established. In the same year, Xiangjiang Pharmaceutical Co., Ltd. was established. Qianjin pharmaceutical invested 8.16 million yuan, accounting for 51% of the total share capital. In the same year, Zhuzhou Qianjin Pharmaceutical Trading Co., Ltd. was established with a registered capital of 5 million yuan. Qianjin pharmaceutical and Xiangjiang pharmaceutical invested 4.8 million yuan and 200000 yuan respectively.

本文链接: https://www.waitui.com/brand/db288be38.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

上海市副市长陈杰:加快建设人工智能“上海高地”,壮大开源社区力量

36氪获悉,2月23日,2025全球开发者先锋大会在上海徐汇召开,上海市副市长陈杰出席开幕式并发表致辞。陈杰指出,面对人工智能快速迭代、模型开源的新趋势,上海将继续发挥超大城市的综合优势,加快建设更具国际影响力的人工智能“上海高地”。进一步完善开源开放生态系统,夯实“语料开放+模型开源”服务体系,不断壮大开源社区力量,推动基础模型、算法和数据资源的共享与开放,构建开放协作、互利共赢的创新环境。(中国基金报)

57分钟前

清华AIR联合水木分子开源DeepSeek版多模态生物医药大模型BioMedGPT-R1

36氪获悉,清华大学人工智能产业研究院(AIR)和北京水木分子生物科技有限公司近日携手推出了升级版的生物医药多模态开源基础大模型BioMedGPT-R1。此前,在2023年,双方合作发布了开源可商用、生物医药多模态百亿参数开源基础大模型BioMedGPT,水木分子发布了自研千亿参数多模态生物医药专业大模型Chat DD-FM和新一代AI驱动药物发现工具Chat DD。这次DeepSeek版ChatDD- R1基座模型也已同步上线ChatDD,赋能生物医药企业的药物研发。

57分钟前

TCL李东生:中国制造未来在海外最大增量大概率来自新兴市场

36氪获悉,TCL&奥林匹克全球合作伙伴签约仪式近日在北京举行。会后,TCL创始人、董事长李东生接受记者采访时表示,当前全球产业链面临转移与重构,持续由全球化向区域化、本土化方向发展。中国制造未来在海外最大的增量空间大概率来自新兴市场,比如巴西等新兴经济体。目前TCL海外制造基地分布在越南、马来西亚、菲律宾、印尼、印度、巴基斯坦、波兰、墨西哥、巴西等九个国家,实现东南亚、南亚、欧洲、北美、南美等各大区域本土化制造布局。未来,会持续关注新兴市场的增长潜力。

57分钟前

深圳:来深毕业生免费7天住升级为15天

为方便各地高校毕业生来深找工作,深圳相继推出“青年驿站”“深梦启航”“深梦扬帆”等“深梦”系列公益活动,为各地来深高校毕业生提供免费7天居住福利,解决他们阶段性、过渡性的居住需求。 2月23日,深圳市政府新闻办召开“打造最好科技创新生态和人才发展环境”新闻发布会。市委科创委办公室主任、科技创新局局长张林在会上透露,深圳为高校应届毕业生来深求职提供免费住宿天数,将从7天延长到15天。 (深圳特区报)

57分钟前

湖南规范互联网医院处方行为:严禁使用AI等自动生成处方

36氪获悉,湖南省医保局近日发布《关于进一步加强基本医疗保障定点零售药店管理的通知》。通知中提到,规范互联网医院处方行为。对互联网医院处方有如下几个措施:①压实实体医疗机构责任。依托实体医疗机构与市级医保部门签订补充协议,强化实体医疗机构的管理责任,因互联网医院违规被解除补充协议的原则上同步解除实体医疗机构医保定点协议,依托的实体医疗机构原则上应为二级及以上医疗机构。②纳入医保管理范畴。在本统筹区提供处方服务的由本市医保中心签协议后公布,跨市州提供处方服务的先征得药店所在地市级医保中心同意,再报省医保中心审定公布。③接入处方流转平台。互联网医院须按规定接入省医保电子处方中心并进行电子处方流转。④明确处方要求。处方行为必须符合行业主管部门管理办法,应与患者或患者家属进行有效、充分的沟通问诊,严禁使用人工智能等自动生成处方。

57分钟前

本页详细列出关于Primera芙莉美娜的品牌信息,含品牌所属公司介绍,Primera芙莉美娜所处行业的品牌地位及优势。
咨询